EQTY Lab Briefing Note
Axendia was briefed by the executive team at EQTY Lab, including Dr. Tina Dr. Morrison, VP Scientific Strategy and Alistair Dootson, Head of Life Sciences. The team provided insights into the company’s foundational vision, current initiatives, and technological framework, particularly with applications within the life sciences sector. They shared the company’s strategy for addressing challenges in artificial intelligence (AI) systems, emphasizing how EQTY’s tools support Life Science industry requirements.
EQTY Lab is dedicated to ensuring every AI system is transparent and secure for a safer, smarter future. The company was founded on principles rooted in the experience of its founder, Jonathan Dotan, whose work with the Starling Lab at Stanford focused on ensuring data integrity for journalists. This foundation has evolved into a broader mission of fostering trust in systems through innovative tools and technologies. EQTY offers solutions tailored to meet the stringent regulatory requirements of the life sciences sector.
Traceability from the Data Origin to Output
AI systems are increasingly integrated into critical operations in the life sciences sector, yet concerns about data transparency, security, and compliance persist. This industry is heavily regulated, with requirements for accurate data documentation and traceability to protect patient safety and ensure research validity.
EQTY’s initiatives center on ensuring the reliability and transparency of AI systems within the life sciences industry. Dr. Morrison explained “The mission of the company is to ensure every AI system is transparent and secure for a safer, smarter future. We call this AI integrity.” This vision translates into a focus on processes that establish the authenticity of data throughout its lifecycle—an essential factor for life science organizations.
Dr. Morrison elaborated on EQTY’s tools, stating, “EQTY Lab builds tools for capturing the integrity of a company’s information supply chain. This involves using cryptographic digests, like hashes, to unlock the authenticity of data at the moment it’s recorded.” By leveraging cryptographic proofs, EQTY enables life sciences organizations to demonstrate compliance and ensure data authenticity as it used and transformed in complex workflows. These proofs serve as verifiable evidence, offering tamper-evident traceability from the data’s origin to its output.
EQTY’s technological offerings support critical operations, including safeguarding research data, verifying clinical trial documentation, and maintaining the integrity of supply chain records, ultimately promoting safer and smarter advancements in the field.
Dr. Morrison emphasized the company’s commitment to enhancing operational transparency, stating, “EQTY’s End-to-end Lineage automatically documents and authenticates data provenance and transformations across systems at the file, variable, or data-point levels. Our ready to deploy tools provide end-to-end visibility across the data lifecycle, enabling organizations to track SOP compliance and adhere to stringent reporting requirements. This capability is vital for fostering trust and ensuring ethical data practices in the life sciences sector.”
Technological Features Supporting Life Sciences
EQTY employs cryptographic digests to safeguard data integrity at the point of capture. Dr. Morrison noted, “With those artifacts, we can establish lineage and authorship of every point in the data pipeline from the source of the data to the output.” This focus on traceability aligns with the regulatory requirements in the life sciences sector for accountability, particularly in clinical trials, real-world evidence and supply chain management where precise data handling is crucial.
Dootson, emphasized the practicality of EQTY’s approach for the life sciences, stating, “It’s not just about compliance for the sake of regulation—it’s about creating systems that organizations can trust and rely on for decision-making.” This perspective highlights EQTY’s broader goal of fostering trust in AI systems through rigorous data management practices tailored for industry applications.
Innovative Approaches to AI Data Integrity
EQTY’s initiatives support broader movements within the life sciences and compliance sectors for ethical AI adoption based on traceable data processes.
According to Dootson, “EQTY provides an advanced framework for data integrity, enabling interoperable and verifiable lineage and governance across diverse systems and organizations. Our tools offer complete traceability to the data source, with drill-down capabilities to the data-point level, ensuring precision and accountability. Through clickable URLs embedded within the data structure, users can easily access specific datasets, fostering process transparency and facilitating version control. Additionally, EQTY’s solutions include visualizations for privacy and governance, offering organizations a comprehensive view of lineage and traceability across multiple systems, thus ensuring trust and compliance in complex data environments.”
Data Integrity Challenges Create Opportunity
Organizations within the life sciences sector face a complex landscape as they integrate AI into critical operations. Dr. Morrison acknowledged these challenges, explaining that EQTY’s goal is to address both transparency and security concerns. The company’s approach provides a framework for managing data integrity while adhering to strict regulatory requirements.
Dootson highlighted the opportunities AI integrity presents for the life sciences: “If organizations can demonstrate transparent and secure processes, it opens doors for collaboration and innovation without compromising trust.”
“EQTY’s tools offer a pathway to achieving these objectives, positioning the company as an important contributor to sustainable AI integration in healthcare and medicine”, added Dr. Morrison.
Dootson emphasized that achieving AI integrity is not merely a regulatory requirement but a transformative opportunity for the life sciences sector. He pointed out that by embedding transparency and security into data processes, organizations can build a foundation of trust that extends beyond compliance. This trust, he explained, is crucial for fostering collaboration between stakeholders, such as research institutions, regulatory bodies, and healthcare providers, who rely on shared, credible data to drive innovation.
Dootson also highlighted the role of AI integrity in enabling ethical AI adoption, particularly in sensitive fields like biomedical research and healthcare. Reliable frameworks for data management ensure that AI systems can be audited and held accountable, reducing risks associated with data breaches or inaccuracies. EQTY’s approach, which incorporates real-time cryptographic proofs and traceability, equips organizations to not only meet current regulatory standards but also adapt to evolving ethical guidelines.
AI integrity can help life science organizations streamline operations. By enhancing confidence in data authenticity, organizations can focus their resources on groundbreaking advancements in medical research that improve patient outcomes.
In Brief
EQTY’s work on AI integrity represents a pragmatic approach to addressing challenges in transparency and security within the life sciences industry. By employing cryptographic tools and prioritizing compliance, the company provides life sciences organizations with a reliable framework for managing data integrity. Insights from Dr. Tina Morrison and Alistair Dootson underscore EQTY’s commitment to creating trustworthy systems tailored to support sustainable and ethical AI integration across the life sciences industry.
We will continue to provide updates on EQTY Lab as they become available.
Ready to unlock new opportunities and drive success? Schedule an Analyst Inquiry today to explore how the latest advancements can transform your business. Click on this link to schedule an Analyst Inquiry on this topic.
How Can We Help?
To navigate uncertainty and build resilience, pharmaceutical and medical device companies can gain valuable insights by engaging with Axendia industry experts. Our analyst team brings deep expertise in business trends, regulatory developments, and technology strategies, offering valuable insights to help Life Science companies optimize operations and drive long-term success.
Engage with Axendia to gain the tools and knowledge your organization needs to thrive in the Age of Continuous Disruption.
Stay at the forefront of innovation and technology in life sciences, healthcare, and space-enabled research by connecting with Axendia.
- Follow us on LinkedIn: Join our professional network and stay updated on the latest insights, trends, and case studies. Connect with Axendia on LinkedIn
- Subscribe to Our Updates: Get exclusive insights and thought leadership articles delivered straight to your inbox. Sign up for our newsletter
- Share Your Thoughts: We’d love to hear from you! Contact us to discuss your ideas, challenges, or opportunities. Email Axendia
Let’s drive innovation together!
To discuss how this initiative impacts your organization. Click on this link to schedule an Analyst Inquiry on this topic.
The opinions and analysis expressed in this post reflect the judgment of Axendia at the time of publication and are subject to change without notice. Information contained in this post is current as of publication date. Information cited is not warranted by Axendia but has been obtained through a valid research methodology. This post is not intended to endorse any company or product and should not be attributed as such.